153 related articles for article (PubMed ID: 3216896)
1. Inhibition of neuronal noradrenaline uptake (uptake1) and desipramine binding by N-ethylmaleimide (NEM).
Schömig E; Michael-Hepp J; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):633-6. PubMed ID: 3216896
[TBL] [Abstract][Full Text] [Related]
2. Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.
Bryan-Lluka LJ; Seers H; Sharpe I
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):536-44. PubMed ID: 8740147
[TBL] [Abstract][Full Text] [Related]
3. Binding of 3H-desipramine to the neuronal noradrenaline carrier of rat phaeochromocytoma cells (PC-12 cells).
Bönisch H; Harder R
Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):403-11. PubMed ID: 3821933
[TBL] [Abstract][Full Text] [Related]
4. [Methoxyflurane and ethanol do not inhibit the neuronal uptake of noradrenaline (uptake 1) at the desipramine binding site].
Kress HG; Schömig E
Anaesthesist; 1990 Jul; 39(7):371-4. PubMed ID: 2386305
[TBL] [Abstract][Full Text] [Related]
5. The transport of (+)-amphetamine by the neuronal noradrenaline carrier.
Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):267-72. PubMed ID: 6514010
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs.
Foley KF; Cozzi NV
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):457-61. PubMed ID: 12070759
[TBL] [Abstract][Full Text] [Related]
7. Solubilization and characterization of the 3H-desipramine binding site of rat phaeochromocytoma cells (PC12-cells).
Schömig E; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):412-7. PubMed ID: 3029604
[TBL] [Abstract][Full Text] [Related]
8. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of neuronal noradrenaline transport (uptake1) and desipramine binding by amiloride and ethylisopropylamiloride.
Schömig E; Michael-Hepp J; Schönfeld CL
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):495-501. PubMed ID: 2559331
[TBL] [Abstract][Full Text] [Related]
10. Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier.
Schömig E; Körber M; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):626-32. PubMed ID: 2851105
[TBL] [Abstract][Full Text] [Related]
11. Characterization of xylamine binding to proteins of PC12 pheochromocytoma cells.
Koide M; Cho AK; Howard BD
J Neurochem; 1986 Oct; 47(4):1277-85. PubMed ID: 3746302
[TBL] [Abstract][Full Text] [Related]
12. Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
Zeitner CJ; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):397-402. PubMed ID: 3821932
[TBL] [Abstract][Full Text] [Related]
13. The effect of cocaine and desipramine on neuronal uptake of [3H]-noradrenaline and sensitivity to noradrenaline of rat mesenteric resistance arteries.
Byg AM; Bund S; Mulvany MJ; Aalkjaer C
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):623-30. PubMed ID: 7813121
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization and purification of the neuronal sodium-dependent noradrenaline transporter.
Bönisch H; Martiny-Baron G; Blum B; Michael-Hepp J
J Neural Transm Suppl; 1990; 32():413-9. PubMed ID: 2089105
[TBL] [Abstract][Full Text] [Related]
15. Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site.
Hara K; Yanagihara N; Minami K; Ueno S; Toyohira Y; Sata T; Kawamura M; Brüss M; Bönisch H; Shigematsu A; Izumi F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):328-33. PubMed ID: 9774220
[TBL] [Abstract][Full Text] [Related]
16. Choline+: a substrate of the neuronal noradrenaline carrier in the rat vas deferens.
Ungell AL; Bönisch H; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):223-7. PubMed ID: 3027585
[TBL] [Abstract][Full Text] [Related]
17. Failure of K+ to affect the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
Ungell AL; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):250-4. PubMed ID: 3587371
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the [3H]-desipramine binding site of the bovine adrenomedullary plasma membrane.
Michael-Hepp J; Blum B; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):203-7. PubMed ID: 1333059
[TBL] [Abstract][Full Text] [Related]
19. Effects of monovalent ions on the transport of noradrenaline across the plasma membrane of neuronal cells (PC-12 cells).
Harder R; Bönisch H
J Neurochem; 1985 Oct; 45(4):1154-62. PubMed ID: 4031884
[TBL] [Abstract][Full Text] [Related]
20. Chloride-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
Ungell AL; Oberleithner H; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):65-70. PubMed ID: 2725700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
